HealthCap’s Post

Clinical teams today often don’t have the luxury of investing significant time in learning how to optimize a new technology solution to meet their practice needs. Collaboration between manufacturers, clinical subject-matter experts and clinicians can help to achieve the goal of leveraging new technologies to expand patient access to better treatment options and outcomes. Learn more about how we collaborate to help drive technology adoption and improved utilization. https://bit.ly/46ss8CF

Reflecting on the immeasurable challenges our industry is facing, our ability to incorporate the dynamic evolution of scientific tools with the restrictions adulterated governing agencies put on us, these challenges do not only impact clinical diagnostics but impact our ability to advance medicine. I firmly believe these challenges are meant to be overcome and it will take the brave many to do so in every discipline. Beyond the awareness campaigns been expertly brought forth by The Dark Intelligence Group, Robert Michel, Bruce Quinn, National Independent Laboratory Association, American Clinical Laboratory Association, Jon Harol, etc I am energized to start receiving resources to voice my disapproval of this ruling, delivered by Association for Molecular Pathology (AMP), Innovation Policy Solutions LLC and Jennifer Leib. Yes, we need to plan for adoption, but we also must take action for what is right for patient care. #CRAResolutionDisapprovingtheFDALDTFinalRule https://lnkd.in/eekzmXMm

This article does a great job in highlighting why DCT is great for patients, but challenging for clinical trial staff. From the case of TELEPIK, it's clear that DCT may actually add to the burden of clinical trial staff, requiring them to learn more systems and integrate more technologies. We need a solution that will reduce the burden of trial staff while making trials more accessible for everyone. EHR-to-EDC is that solution. " The lack of integration between technological solutions used in DCTs and hospital-based infrastructure might also have implications in the resources that are needed for study completion." https://lnkd.in/dQfpHucE

Exciting to see Acarix advancing cardiac diagnostics! At Rejuve.Bio, we value innovative approaches to healthcare. Our AI-driven research aims to revolutionize longevity interventions, aligning with Acarix's goal of improving patient outcomes. Learn more about Rejuve.Bio and our crowdfund here bit.ly/rjvbcrowdfund https://lnkd.in/gKi8RGC4

🔬💼 Boost your trial's success with Clario's scientific expertise! 💡📊 Looking to optimize cardiac safety assessment, eCOA/ePRO and medical imaging endpoints in your clinical trials? Engage our scientists early in the planning process for unparalleled insights and support. Learn more about how trials, large and small, can benefit from Clario scientists: https://hubs.li/Q02dpYW50 #ClinicalTrials #ScientificExpertise

Breaking News 🎉 As we celebrate International Clinical Trials Day, we think it's fitting to share our latest ground-breaking innovation in recruitment pathways for clinical trials. Alongside StrongRoom AI and Paratus Clinical, we have pioneered an Australian-first pilot project - revolutionising how patients access clinical trials. Leveraging GP and pharmacy networks via our product, Evripath, we're connecting patients with ideal-fit trials faster than ever before. Want to learn more about our pioneering recruitment pathways? Head to our website for the full story! #InternationalClinicalTrialsDay #ClinicalTrials #PatientRecruitment #MedicalResearch #HealthTech #AustralianFirst #Innovation #Evripath #StrongRoomAI #ParatusClinical #EvrimaTechnologies

What's the longest you've had to wait to confirm if your sample has arrived at a lab and been logged into their database? A few days? A week? Even longer? This lack of visibility into a sample's journey has become the norm — but it shouldn't be. Learn more below about why your trial's success depends on gaining faster and more complete visibility into lab activities. #clinicaltrials #clinicalresearch #samplemanagement #labqueries #clinicaloperations

At Miami Clinical Research, we understand the intricate demands of clinical trials. With a state-of-the-art facility, including specialized labs and advanced imaging technologies, we’re equipped to handle the most complex research needs. Learn how our unparalleled infrastructure supports groundbreaking medical advancements. Read more: https://lnkd.in/gvkTBPG3 #medicalresearch #clinicaltrials #medicalstudies #miamiclinicalresearch #pharmaceuticalresearch #clinicalimaging #biomedicalresearch #medicalinnovation 

Explore the benefits of a clinical logistics monitor to expertly guide the cellular starting material and subsequent therapy through the clinical trial journey.

Congratulation's to the CSA Medical team. Another great success for cryoablation! As the success stories for cryoablation continue to mount, one has to ask where is the investment community? Never thought he the view from the sidelines was that good myself. On the field, that is where the action is. Where winners are forged. Next generation devices such as Phase Tx.'s revolutionary EUS compatible cryoablation catheter FrostBite, will further the evolution of cryoablation. FrostBite incorporates a EUS guided minimally invasive approach into the ablation process, enabling real time visualization and increased access to the pancreas while rapidly delivering the highly destructive ablative capacity of freezing. https://lnkd.in/eYBVqT6i Phase Tx. is actively seeking Series A funding to bring this exciting new technology to the market. Great ground floor opportunity for investors. Want in the game, learn more at www.PhaseTx.com #cryotherapy #lungcancer #bronchoscopy #endoscopy #EUS #CPSIBiotech #PhaseTx #cryosurgery #cryoablation #makeadifferece #NIH #pancreaticcancer #SBA #venturecaptial #familyoffce #cryo #getoffthebench #SBIR #NCI #medtech #tech #innovation #startups #entrepreneurs #entrepreneurship #vc #money #business #cancertherapy